Understand the complete disease landscape and size global markets with real-world data. DRG’s Epidemiology cover 140+ diseases, 40+ countries, 3,400 patient segments, including extensive insights of oncology populations by stage, line of therapy, and biomarker. Learn more about DRG Epidemiology here.

The poster below was presented by DRG Epidemiologist Ruchika Sharma at Global Hepatitis Summit 2018 on The Global Impact of Direct Acting Antivirals on Hepatitis C Virus Burden: A Ten-Year Forecast.




Mainland China’s anticipated biosimilar boom – potential and key drivers of the market

View Now